For information about COVID-19, including symptoms and prevention, please read our COVID-19 patient guide. Please also consider supporting Weill Cornell Medicine’s efforts against the pandemic.

Bench to Bedside Initiative Entrepreneurship Kickoff + Networking Evening

Come meet aspiring entrepreneurs, inventors, scientists, clinicians, engineers and business professionals. Network with future teammates for our December Pitch Day!

Keynote Renier Brentjens, MD, PhD, Director, Cellular Therapeutics, MSKCC; Scientific Co-Founder of Juno Therapeutics (JUNO).

Featuring three BBI alumni startups:

Frank Borchetta, JD, Founder and CEO, Repairogen.

Kevin O'Rourke, MD, PhD candidate, Co-Founder, York Avenue Diagnostics.

Kate Rochlin, PhD, Founder and CSO, Immunovent.

The Bench to Bedside Initiative (BBI) is supported in part by Weill Cornell Medicine Dean's Entrepreneurship Lab. This event is the beginning of our 12-week seminar series. All attendees are encouraged to form teams and to write business plans around patented technologies invented at Cornell University, Memorial Sloan Kettering Cancer Center and Rockefeller University.

Tuesday, September 13, 2016 from 6:00 PM to 7:30 PM (EDT) - Add to Calendar
Zuckerman Auditorium, Memorial Sloan Kettering Cancer Center - 417 E. 68th St. - View Map
Ready to start?
Apply now
Need more info?
Ask a question
Follow us on

Weill Cornell Medicine Graduate School of Medical Sciences 1300 York Ave. Box 65 New York, NY 10065 Phone: (212) 746-6565 Fax: (212) 746-5981